diphenyleneiodonium has been researched along with Dermatitis, Atopic in 1 studies
diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Emmert, H | 1 |
| Fonfara, M | 1 |
| Rodriguez, E | 1 |
| Weidinger, S | 1 |
1 other study available for diphenyleneiodonium and Dermatitis, Atopic
| Article | Year |
|---|---|
NADPH oxidase inhibition rescues keratinocytes from elevated oxidative stress in a 2D atopic dermatitis and psoriasis model.
Topics: Cells, Cultured; Dermatitis, Atopic; DNA Damage; Enzyme Inhibitors; Humans; Hydrogen Peroxide; In Vi | 2020 |